Atherosclerosis vaccine (AFFiRiS)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameAtherosclerosis vaccine (AFFiRiS)
Drug Alias NameATH-03
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsHyperlipoproteinemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAffiris Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffiris Ag
Active IndicationsN/A
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsHyperlipoproteinemias

Other Information

ATC CodeN/A
Related LinksN/A